The clinical development process for a novel preventive vaccine: An overview

K Singh, S Mehta - Journal of postgraduate medicine, 2016 - journals.lww.com
Each novel vaccine candidate needs to be evaluated for safety, immunogenicity, and
protective efficacy in humans before it is licensed for use. After initial safety evaluation in …

Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far

T Agorastos, K Chatzigeorgiou, JML Brotherton… - Vaccine, 2009 - Elsevier
Despite the advent of the Papanicolaou smear test almost 50 years ago, cervical cancer
remains the second most common malignant disease in women and the leading cause of …

A randomized, controlled trial of an aerosolized vaccine against measles

N Low, A Bavdekar, L Jeyaseelan… - … England Journal of …, 2015 - Mass Medical Soc
Background Aerosolized vaccine can be used as a needle-free method of immunization
against measles, a disease that remains a major cause of illness and death. Data on the …

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques

KR Bewley, K Gooch, KM Thomas, S Longet… - Science …, 2021 - science.org
There is an urgent requirement for safe and effective vaccines to prevent COVID-19. A
concern for the development of new viral vaccines is the potential to induce vaccine …

Needle size for vaccination procedures in children and adolescents

PV Beirne, S Hennessy, SL Cadogan… - Cochrane database …, 2015 - cochranelibrary.com
Antecedentes En los procedimientos de vacunación se pueden utilizar agujas hipodérmicas
de diferentes tamaños (calibres y longitudes). El calibre (G, del inglés" gauge") se refiere al …

TBVAC2020: advancing tuberculosis vaccines from discovery to clinical development

SHE Kaufmann, HM Dockrell, N Drager… - Frontiers in …, 2017 - frontiersin.org
TBVAC2020 is a research project supported by the Horizon 2020 program of the European
Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) …

Consumer reporting of adverse events following immunization

HJ Clothier, G Selvaraj, ML Easton… - Human vaccines & …, 2014 - Taylor & Francis
Surveillance of adverse events following immunisation (AEFI) is an essential component of
vaccine safety monitoring. The most commonly utilized passive surveillance systems rely …

[HTML][HTML] Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women

CE Jones, FM Munoz, HML Spiegel, U Heininger… - Vaccine, 2016 - Elsevier
Vaccination during pregnancy is increasingly being used as an effective approach for
protecting both young infants and their mothers from serious infections. Drawing conclusions …

[HTML][HTML] Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case …

L Schönborn, S Pavord, VMY Chen, M Pai, DH Gwarzo… - Vaccine, 2024 - Elsevier
This is a revision of the online November 2021 Brighton thrombosis with thrombocytopenia
syndrome (TTS) case definition and a new Brighton Collaboration case definition for vaccine …

[PDF][PDF] Immunization safety surveillance: guidelines for immunization programme managers on surveillance of adverse events following immunization

World Health Organization - 2016 - apps.who.int
Immunization Safety Surveillance Page 1 Immunization Safety Surveillance Guidelines for
immunization programme managers on surveillance of adverse events following immunization …